BCR and B-cell chronic lymphocytic leukemia: Functional evidence indicates that BCR pathway activation in CLL derives from contacts between tumor cells and antigens, which are influenced, among other factors, by the SHM action of the rearranged IGHV genes (Vardi et al., 2014).